Loading...
Loading...
Body Protection Compound — Tissue Repair & Cytoprotection Research
Select Size
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a partial sequence of human gastric juice protein BPC, a protective protein naturally present in the stomach. At the molecular level, BPC-157 has been investigated for its ability to upregulate growth factor expression including VEGF, EGF, and their receptors, promoting angiogenesis and accelerating the formation of granulation tissue in preclinical wound models. Published literature suggests it modulates the nitric oxide (NO) system, the FAK-paxillin pathway involved in cell migration, and the JAK-2/STAT-3 signaling cascade linked to tissue remodeling. Preclinical research has demonstrated accelerated healing rates in tendons, ligaments, muscles, and gastrointestinal mucosa, with studies reporting significant improvements in collagen organization and tensile strength at injury sites. What makes BPC-157 particularly notable in the research literature is its cytoprotective profile — it has been studied for protective effects against NSAID-induced gastrointestinal lesions, alcohol toxicity, and various organ damage models, distinguishing it from peptides that target only a single tissue type. Currently, BPC-157 remains in the preclinical research stage with extensive in-vivo animal studies published across multiple independent laboratories, though no completed human clinical trials have been reported to date.
Published research protocols reference daily subcutaneous administration. Store refrigerated at 2-8°C.
Published research protocols reference 250-750mcg daily. Consult applicable literature for specific research applications.
Preclinical studies demonstrate that BPC-157 enhances healing of muscles, tendons, and ligaments by upregulating VEGF-mediated angiogenesis and modulating growth factor receptor expression at injury sites. Research in rat models has shown significantly improved collagen fiber organization and earlier restoration of tensile strength compared to controls.
Initial effects within first month
Published research suggests BPC-157 modulates the inflammatory cascade by influencing nitric oxide system balance and reducing pro-inflammatory cytokine expression. In multiple preclinical models, it has been investigated for attenuation of edema, leukocyte infiltration, and oxidative stress markers, supporting a faster transition from the inflammatory to the proliferative healing phase.
Initial effects within first month
Research Studies
Originally isolated from gastric juice, BPC-157 has been extensively studied for gastrointestinal cytoprotection. Preclinical literature reports protective effects against NSAID-induced gastric lesions, alcohol-related mucosal damage, and inflammatory bowel models, with proposed mechanisms involving tight junction protein upregulation and mucosal blood flow enhancement.
Initial effects within first month
Research Studies
BPC-157 in lyophilized (freeze-dried) form should be stored at -20°C for long-term stability, where it remains viable for up to 24 months. Once reconstituted with bacteriostatic water, store at 2-8°C and use within 30 days. BPC-157 is relatively stable among peptides, but repeated freeze-thaw cycles should be avoided to preserve structural integrity.
Our BPC-157 is verified at 99%+ purity through independent third-party HPLC analysis at Janoshik Analytical Laboratory. Each batch is additionally tested via mass spectrometry to confirm molecular identity (MW 1419.53 Da for the free acid form), along with sterility and endotoxin screening. Certificates of Analysis are available for every batch.
Each vial is formulated to provide the specified supply duration based on dosage ranges cited in published BPC-157 research literature, typically 250-750mcg per day. The 5mg vial supports lower-dose protocols while the 10mg vial accommodates higher-dose research designs referenced in the peer-reviewed literature.
Currently we ship to all 50 US states with free standard shipping. Express shipping (2-3 business days) is available for $9.99. International shipping is coming soon.
BPC-157 is sold strictly for in-vitro research, laboratory use, and educational purposes. While extensive preclinical animal studies have been published across multiple independent laboratories, no completed human clinical trials are currently available. This product is not intended for human consumption or self-administration. Always consult applicable regulations in your jurisdiction.
Important Notice
Not for human consumption. This product is sold exclusively for in-vitro research and laboratory use. It is not a drug, supplement, food item, or cosmetic and has not been evaluated by the FDA.
The research data and clinical references cited on this page are provided for educational reference only and do not constitute medical advice. This product must be handled by qualified research professionals in accordance with all applicable institutional and regulatory guidelines.
Use is restricted to qualified researchers or laboratories operating within appropriate legal and ethical research guidelines. By purchasing, you confirm you are acquiring this product solely for lawful research purposes.
Published research and educational content related to BPC 157
A detailed comparison of two of the most studied recovery peptides in preclinical research, examining their distinct mechanisms, published findings, and how investigators approach studying them individually and in combination.
A comprehensive look at the scientific literature behind BPC-157, one of the most studied peptides for tissue repair and recovery.
A review of preclinical research on peptides like BPC-157 and TB-500 and their potential roles in tissue repair and recovery processes.
An exploration of the leading peptides and peptide-related compounds being studied in cellular aging research, from telomere biology and Epithalon to mitochondrial-targeted peptides and NAD+ precursors.